Interleukin-1 Blockade in Recently Decompensated Systolic Heart Failure: Results from the REcently Decompensated Heart failure Anakinra Response Trial (REDHART)

BACKGROUND: An enhanced inflammatory response predicts worse outcomes in heart failure (HF). We hypothesized that administration of Interleukin-1 (IL-1) receptor antagonist (anakinra) could inhibit the inflammatory response and improve peak aerobic exercise capacity in patients with recently decompe...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Circ Heart Fail
المؤلفون الرئيسيون: Van Tassell, Benjamin W., Canada, Justin, Carbone, Salvatore, Trankle, Cory, Buckley, Leo, Erdle, Claudia Oddi, Abouzaki, Nayef A., Dixon, Dave, Kadariya, Dinesh, Christopher, Sanah, Schatz, Aaron, Regan, Jessica, Viscusi, Michele, Buono, Marco Del, Melchior, Ryan, Mankad, Pranav, Lu, Juan, Sculthorpe, Robin, Biondi-Zoccai, Giuseppe, Lesnefsky, Edward, Arena, Ross, Abbate, Antonio
التنسيق: Artigo
اللغة:Inglês
منشور في: 2017
الموضوعات:
Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC5699505/
https://ncbi.nlm.nih.gov/pubmed/29141858
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCHEARTFAILURE.117.004373
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة